Found: 24
Select item for more details and to access through your institution.
Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (GO TEST Finale): study protocol of a multicentre pragmatic randomized superiority trial.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07242-y
- By:
- Publication type:
- Article
Extra-articular findings with FDG-PET/CT in rheumatoid arthritis patients: more harm than benefit.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 1, p. 1, doi. 10.1093/rap/rkac014
- By:
- Publication type:
- Article
(Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges.
- Published in:
- Rheumatology Advances in Practice, 2021, v. 5, n. 1, p. 1, doi. 10.1093/rap/rkab007
- By:
- Publication type:
- Article
Limited Diagnostic and Prognostic Value of Routine Radiographs in Newly Presenting Arthritis Suspected of Rheumatoid Arthritis: A Retrospective Study.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 4, p. 497, doi. 10.1002/acr.25271
- By:
- Publication type:
- Article
PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
(Dis)agreement of polymyalgia rheumatica relapse criteria, and prediction of relapse in a retrospective cohort.
- Published in:
- BMC Rheumatology, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41927-022-00274-y
- By:
- Publication type:
- Article
Therapy with JAK inhibitors or bDMARDs and the risk of cardiovascular events in the Dutch rheumatoid arthritis population.
- Published in:
- Rheumatology, 2024, v. 63, n. 8, p. 2142, doi. 10.1093/rheumatology/kead531
- By:
- Publication type:
- Article
The added value of predictive biomarkers in treat-to-target strategies for rheumatoid arthritis patients: a conceptual modelling study.
- Published in:
- Rheumatology, 2023, v. 62, n. 8, p. 2700, doi. 10.1093/rheumatology/keac709
- By:
- Publication type:
- Article
Seroconversion after a third COVID-19 vaccine is affected by rituximab dose but persistence is not in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 4, p. 1627, doi. 10.1093/rheumatology/keac486
- By:
- Publication type:
- Article
Rituximab dose-dependent infection risk in rheumatoid arthritis is not mediated through circulating immunoglobulins, neutrophils or B cells.
- Published in:
- Rheumatology, 2023, v. 62, n. 1, p. 330, doi. 10.1093/rheumatology/keac318
- By:
- Publication type:
- Article
Drug levels, anti-drug antibodies and B-cell counts were not predictive of response in rheumatoid arthritis patients on (ultra-)low-dose rituximab.
- Published in:
- Rheumatology, 2022, v. 61, n. 10, p. 3974, doi. 10.1093/rheumatology/keac024
- By:
- Publication type:
- Article
Humoral response to coronavirus disease-19 vaccines is dependent on dosage and timing of rituximab in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2022, v. 61, p. SI175, doi. 10.1093/rheumatology/keac206
- By:
- Publication type:
- Article
Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study.
- Published in:
- Rheumatology, 2022, v. 61, n. 6, p. 2307, doi. 10.1093/rheumatology/keab741
- By:
- Publication type:
- Article
Effectiveness and tolerability of oral vs subcutaneous methotrexate in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2022, v. 61, n. 1, p. 331, doi. 10.1093/rheumatology/keab313
- By:
- Publication type:
- Article
Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis.
- Published in:
- Rheumatology, 2020, v. 59, n. 7, p. 1550, doi. 10.1093/rheumatology/kez487
- By:
- Publication type:
- Article
Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The value of routine creatine kinase and thyroid stimulating hormone testing in patients with suspected fibromyalgia: a cross-sectional study.
- Published in:
- Rheumatology, 2016, v. 55, n. 7, p. 1273, doi. 10.1093/rheumatology/kew046
- By:
- Publication type:
- Article
Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 7, p. 2936, doi. 10.1007/s10620-023-07950-0
- By:
- Publication type:
- Article
Non‐Medical Switching from Tocilizumab to Sarilumab in Rheumatoid Arthritis Patients with Low Disease Activity, an Observational Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 810, doi. 10.1002/cpt.2999
- By:
- Publication type:
- Article
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of add-on methotrexate in polymyalgia rheumatica patients flaring on glucocorticoids tapering: a retrospective study.
- Published in:
- Rheumatology International, 2021, v. 41, n. 3, p. 611, doi. 10.1007/s00296-020-04783-2
- By:
- Publication type:
- Article
Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study).
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2022, p. 1, doi. 10.1177/1759720X221142277
- By:
- Publication type:
- Article
Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article